Literature DB >> 2896039

Myocardial infarction: the first 24 hours.

D P Lipkin1, C J Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2896039      PMCID： PMC2545426          DOI： 10.1136/bmj.296.6627.947

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  11 in total

1.  Trial of early nifedipine in acute myocardial infarction: the Trent study.

Authors:  R G Wilcox; J R Hampton; D C Banks; J S Birkhead; I A Brooksby; C J Burns-Cox; M J Hayes; M D Joy; A D Malcolm; H G Mather
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

2.  Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.

Authors:  H K Gold; R C Leinbach; H D Garabedian; T Yasuda; J A Johns; E B Grossbard; I Palacios; D Collen
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

3.  Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy.

Authors:  D Hackett; G Davies; S Chierchia; A Maseri
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

4.  Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

Authors:  K I Lie; H J Wellens; F J van Capelle; D Durrer
Journal:  N Engl J Med       Date:  1974-12-19       Impact factor: 91.245

Review 5.  Coronary thrombolysis.

Authors:  D de Bono
Journal:  Br Heart J       Date:  1987-04

6.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

7.  Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials.

Authors:  R A DeSilva; C H Hennekens; B Lown; W Casscells
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

8.  Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

Authors:  R S Gibson; W E Boden; P Theroux; H D Strauss; C M Pratt; M Gheorghiade; R J Capone; M H Crawford; R C Schlant; R E Kleiger
Journal:  N Engl J Med       Date:  1986-08-14       Impact factor: 91.245

9.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

Authors:  E J Topol; R M Califf; B S George; D J Kereiakes; C W Abbottsmith; R J Candela; K L Lee; B Pitt; R S Stack; W W O'Neill
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245

10.  Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.

Authors:  M L Simoons; A E Arnold; A Betriu; D P de Bono; J Col; F C Dougherty; R von Essen; H Lambertz; J Lubsen; B Meier
Journal:  Lancet       Date:  1988-01-30       Impact factor: 79.321
View more
  2 in total

1.  Low back pain associated with streptokinase.

Authors:  M Shah; R T Taylor
Journal:  BMJ       Date:  1990-11-24

2.  Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.

Authors:  K A Davies; P Mathieson; C G Winearls; A J Rees; M J Walport
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.